D.A. Davidson & Co. Abiomed Inc Transaction History

D.A. Davidson & Co.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 05, 2019	SELL	$175.89 - $279.23 $147,219 - $233,715	-837 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$250.96 - $284.94 $113,182 - $128,507	-451 Reduced 35.02%	837 $218,000
Q1 2019 May 13, 2019	BUY	$276.39 - $362.25 $22,663 - $29,704	82 Added 6.8%	1,288 $386,000
Q3 2018 Nov 13, 2018	SELL	$354.53 - $449.75 $29,071 - $36,879	-82 Reduced 6.37%	1,206 $542,000
Q2 2018 Aug 02, 2018	BUY	$278.07 - $446.21 $89,260 - $143,233	321 Added 33.2%	1,288 $527,000
Q1 2018 May 04, 2018	BUY	$192.49 - $295.85 $186,137 - $286,086	967 New	967 $281,000
Q3 2017 Nov 08, 2017	SELL	$145.39 - $168.6 $43,616 - $50,580	-300 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	300	300 $0

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.